Z. Kiss et al., STIMULATION OF DNA-SYNTHESIS IN UNTRANSFORMED CELLS BY THE ANTIVIRAL AND ANTITUMORAL COMPOUND TRICYCLODECAN-9-YL-XANTHOGENATE (D609), Biochemical pharmacology, 55(6), 1998, pp. 915-918
The antiviral and antitumor xanthate compound tricyclodecan-9-yl-xanth
ogenate (D609) is best known for its inhibitory effect on phosphatidyl
choline-specific phospholipase C activity. Now we report that in NIH 3
T3 cells, but not in several transformed cell types tested, D609 stimu
lated DNA synthesis when phosphocholine (PCho), insulin, or ATP was al
so present. Maximal co-mitogenic effects of D609 were observed at 5 mu
g/mL, a concentration 4-6 times lower than that required to inhibit p
hospholipase C activity. The synergistic mitogenic effects of D609 and
PCho, but not of D609 and insulin, were associated with activation of
p42 and, to a lesser extent, p44 mitogen-activated protein (MAP) kina
ses. The results raise the possibility that the mitogenic activity of
D609 in untransformed cells may contribute to its antiviral and antitu
mor effects. (C) 1998 Elsevier Science Inc.